Evidence map›Paper›PMID 40330583›Full record

ArticleContemporary clinical trials communications2025

Study protocol: Apps and peer support for a healthy future and living well with diabetes (APHLID-M).

K O Mathews, F MacMillan, V Wong, M Craig, J R Greenfield, R Hicks, T Jones, A Poynten, T Wong, M Reyes and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Contemporary clinical trials communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

K O MathewsSchool of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
F MacMillanOffice of the Senior Deputy Vice-Chancellor and Vice-President (Research, Enterprise and Global), Western Sydney University, Penrith, Australia.
V WongLiverpool Hospital, Australia.
M CraigSydney Children's Hospital Westmead, University of NSW, Australia.
J R GreenfieldSt Vincent's Hospital, University of NSW, Australia.
R HicksSchool of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
T JonesGoulburn Valley Health, Australia.
A PoyntenPrince of Wales Hospital, Australia.
T WongBankstown Hospital, Australia.
M ReyesSt George Hospital, Australia.
K TannousSchool of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
C WilsonSchool of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
P HaySchool of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
S AbdoBankstown Hospital, Australia.
M K PiyaSchool of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
J LaiLiverpool Hospital, Australia.
M VenigallaSchool of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
R ThomsonAnalytical Edge Pty Ltd, Australia.
D SimmonsSchool of Medicine, Western Sydney University, Campbelltown, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mental health conditions are common among non-pregnant young people with any form of diabetes, affecting diabetes self-management and increasing complications risk. Limited evidence exists on whether smartphone applications "apps" combining diabetes and mental health (MH) support can improve self-management and MH in these young people. The Apps and Peer support for a Healthy future and Living Well with Diabetes (APHLID-M) multicentre study includes two randomised controlled trials (RCTs) testing such an app, aimed at reducing distress among young adults with diabetes with and without a mental health condition (MHC). Methods and analysis: An app containing diabetes and MH resources was configured onto a pre-existing, digital health platform. Young adults aged 16-30 years with diabetes will be recruited from eight Australian outpatient clinics, screened using the Kessler Psychological Distress Scale (K10) and the Problem Areas in Diabetes (PAID) questionnaires. Based on MH status, participants will be allocated to the primary RCT (MHC group) or a nested-exploratory RCT (No-MHC group) and randomised by site to the "app" (Intervention) or "no app" (control). All participants will have access to peer support and will continue to receive standard diabetes care through their clinic. Recruitment will end once 142 participants are enrolled in the primary RCT. The primary outcome is change in psychological distress (K10), and the secondary outcome change in HbA1c, assessed at baseline and 6 months. Discussion: APHLID-M will offer valuable insights into effects of digital technology in enhancing MH (particularly distress) physical health and well-being in young people with diabetes.

Indexed as

DiabetesDigital health appHealthMentalYoung adults

Identifiers

PMID40330583
PMCPMC12052685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.